As of 2024-12-06, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -0.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 180.55 mil USD. BLUE's TTM EBITDA according to its financial statements is -201.57 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 15.6x | 14.5x |
| Forward P/E multiples | 13.6x - 15.8x | 15.4x |
| Fair Price | (14.62) - (16.74) | (16.02) |
| Upside | -3710.5% - -4232.7% | -4056.1% |
| Date | EV/EBITDA |
| 2024-11-29 | -0.90 |
| 2024-11-27 | -0.87 |
| 2024-11-26 | -0.86 |
| 2024-11-25 | -0.85 |
| 2024-11-22 | -0.84 |
| 2024-11-21 | -0.79 |
| 2024-11-20 | -0.80 |
| 2024-11-19 | -0.80 |
| 2024-11-18 | -0.83 |
| 2024-11-15 | -0.81 |
| 2024-11-14 | -0.85 |
| 2024-11-13 | -0.87 |
| 2024-11-12 | -0.88 |
| 2024-11-11 | -0.90 |
| 2024-11-08 | -0.90 |
| 2024-11-07 | -0.87 |
| 2024-11-06 | -0.93 |
| 2024-11-05 | -0.94 |
| 2024-11-04 | -0.95 |
| 2024-11-01 | -0.95 |
| 2024-10-31 | -0.95 |
| 2024-10-30 | -0.98 |
| 2024-10-29 | -0.98 |
| 2024-10-28 | -0.98 |
| 2024-10-25 | -0.97 |
| 2024-10-24 | -0.99 |
| 2024-10-23 | -1.00 |
| 2024-10-22 | -0.99 |
| 2024-10-21 | -0.98 |
| 2024-10-18 | -0.98 |
| 2024-10-17 | -0.97 |
| 2024-10-16 | -0.97 |
| 2024-10-15 | -0.97 |
| 2024-10-14 | -0.99 |
| 2024-10-11 | -0.99 |
| 2024-10-10 | -0.98 |
| 2024-10-09 | -0.98 |
| 2024-10-08 | -0.98 |
| 2024-10-07 | -1.01 |
| 2024-10-04 | -1.05 |
| 2024-10-03 | -1.00 |
| 2024-10-02 | -0.98 |
| 2024-10-01 | -0.96 |
| 2024-09-30 | -1.01 |
| 2024-09-27 | -0.99 |
| 2024-09-26 | -0.98 |
| 2024-09-25 | -0.97 |
| 2024-09-24 | -0.99 |
| 2024-09-23 | -0.98 |
| 2024-09-20 | -0.96 |